Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study for Novel Coronavirus Pneumonia (NCP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04283396
Recruitment Status : Recruiting
First Posted : February 25, 2020
Last Update Posted : March 17, 2020
Sponsor:
Information provided by (Responsible Party):
Yang Jin, Wuhan Union Hospital, China

Brief Summary:
To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

Condition or disease Intervention/treatment
Novel Coronavirus Pneumonia Combination Product: systemic treatment

Detailed Description:
By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Study for Clinical Epidemiology and Methods of Diagnosis and Treatment of Novel Coronavirus Pneumonia (NCP)
Actual Study Start Date : February 21, 2020
Estimated Primary Completion Date : May 30, 2020
Estimated Study Completion Date : July 30, 2020

Resource links provided by the National Library of Medicine



Intervention Details:
  • Combination Product: systemic treatment
    Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin


Primary Outcome Measures :
  1. recovery [ Time Frame: up to 24 weeks ]
    Number of patients recover from novel coronavirus pneumonia



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients confirmed with novel coronavirus pneumonia.
Criteria

Inclusion Criteria:

  • Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial Version 5)";

Exclusion Criteria:

  • Physician judged the patient was not suitable for this clinical trial.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04283396


Contacts
Layout table for location contacts
Contact: Yang Jin 13554361146 whunjy@126.com
Contact: Jiancai Wu 02785726685

Locations
Layout table for location information
China, Hubei
Union hospital Recruiting
Wuhan, Hubei, China, 430000
Contact: Yang Jin    13554361146    whuhjy@126.com   
Contact: Jiancai Wu    02785726685    whunionlunli@126.com   
Sponsors and Collaborators
Wuhan Union Hospital, China
Layout table for additonal information
Responsible Party: Yang Jin, Professor, Wuhan Union Hospital, China
ClinicalTrials.gov Identifier: NCT04283396    
Other Study ID Numbers: NCP01
First Posted: February 25, 2020    Key Record Dates
Last Update Posted: March 17, 2020
Last Verified: March 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: Yes
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronavirus Infections
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Virus Diseases